Get the latest tech news
You can get an at-home flu ‘shot’ starting next year
FluMist is administered as a nasal spray rather than injected.
FluMist — a nasal spray vaccine that AstraZeneca initially developed as an in-office treatment two decades ago — will still require a prescription to obtain and is expected to be made available via a new online pharmacy next year, according to The New York Times. The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or inconvenient to travel for flu immunization treatments. The World Health Organization reports that there are around a billion annual cases of seasonal influenza, resulting in 290,000 to 650,000 respiratory deaths each year.
Or read this on The Verge
